Page results
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the spine (backbone).
-
Bed availability is a “significant” factor in determining whether or not a patient is admitted to a critical care bed after surgery, questioning whether some are getting the care they need, a new study from researchers at UCL and UCLH has found for the first time.
-
Pfizer Limited, in agreement with the Medicines Healthcare products Regulatory Agency (MHRA), has withdrawn the product, while a review of the benefits and risks is carried out.
-
This page is for parents and carers whose child is having radiotherapy treatment to the pelvis.
-
Information for patients from overseas visiting UCLH hospitals.
-
Health secretary Matt Hancock visited University College Hospital yesterday to see for himself our post-Covid-19 service set up to help survivors of the virus with their long-term recovery.
-
This page has been written for patients who are having radioactive iodine (131I) ablation and/or radioiodine treatment for thyroid cancer.
-
Mixed sex accommodation and privacy information for patients coming into hospital for an inpatient stay
-
UCLH NHS Foundation Trust has once again formed a partnership with the Business Design Centre in Islington to reopen a large-scale COVID-19 vaccination centre on site from Saturday 18 December.
-
This page is for patients with obesity who are waiting for scheduled surgery.
File results
-
FOI/2023/0038 - Cases where breast milk of a new mother was given to a child who is not her own
-
FOI/2023/0041 - International recruitment
-
FOI/2023/0054 - Local formulary used at the Trust
-
FOI/2023/0058 - Skin cancer pathway management
-
FOI/2023/0063 - Women who have given birth at the Trust aged 50 or above
-
FOI/2023/0064 - Children's operations cancelled/ delayed for non-clinical reasons from 2018 to 2022
-
FOI/2023/0105 - Maternity services birthing centre
-
FOI/2023/0110 - General anaesthesia paediatric dental waiting times
-
FOI/2023/0109 - UK-EU aggrement S2 funding applications and treatments
-
FOI/2023/0111 - Migraine treatment